METHODS: A mixed retrospective and prospective correlational study.
METHODS: Single tertiary referral center in the United Kingdom.
METHODS: All adult patients undergoing their first BCHI over 6 years (April 1, 2017, to March 3, 2023).
METHODS: The Chronic Otitis Media Benefit Inventory (COMBI) score (postintervention) and the Glasgow Health Status Inventory (GHSI) (pre-and post-BCHI questionnaire).
RESULTS: Improvements were seen across all COMBI domains. The mean total COMBI score was 46.3 (standard deviation = 5.3). Although expected significant improvements were seen in hearing and social domains, there were also notable gains in ear symptoms and reduced medical intervention post-BCHI. There was a statistically significant improvement in all GHSI scores post-BCHI (median total difference 67.1, p < 0.0001).
CONCLUSIONS: This study reports very favorable outcomes for BCHI patients using two different PROMs: COMBI and GHSI. Although these PROMs complement each other, they also offer different perspectives on the same cohort of patients, with COMBI providing a unique insight into specific ear symptoms. This is the first reported study using this complement of PROMS in BCHI patients and offers further evidence for the wide-reaching improvements BCHI can have for patients.
方法:一项混合的回顾性和前瞻性相关研究。
方法:英国的单一三级转诊中心。
方法:所有接受首次BCHI超过6年(2017年4月1日至2023年3月3日)的成年患者。
方法:慢性中耳炎获益量表(COMBI)评分(干预后)和格拉斯哥健康状况量表(GHSI)(BCHI前后问卷)。
结果:在所有COMBI领域都有改善。平均总COMBI评分为46.3(标准偏差=5.3)。尽管在听力和社交领域看到了预期的显着改善,BCHI后,耳部症状也显著增加,医疗干预减少.BCHI后所有GHSI评分均有统计学上的显着改善(中位数总差异67.1,p<0.0001)。
结论:本研究报告BCHI患者使用两种不同的PROM:COMBI和GHSI,结果非常有利。虽然这些PROM相互补充,他们还对同一批患者提供不同的观点,COMBI提供了对特定耳朵症状的独特见解。这是首次报道在BCHI患者中使用这种PROMS补充的研究,并为BCHI对患者的广泛改善提供了进一步的证据。